General

The Invisible Conversation Shaping Your Drug’s Reputation Somewhere right now, a patient is asking an AI chatbot whether their statin […]

Pharmaceutical brands are losing control of their product narrative — not in the press, not at the pharmacy counter, but

Pharmaceutical companies face a new blind spot as patients migrate from search engines to Large Language Models (LLMs) for medical

The era of the ten-blue-link search result is ending. For pharmaceutical marketers, the transition from Google Search to Large Language

Audit ChatGPT for FDA Compliance Pharmaceutical companies face a new regulatory gap as patients and physicians turn to large language

The Problem No One Is Watching Closely Enough Somewhere between a patient typing symptoms into a chatbot and a physician

Patients are asking ChatGPT about your drug. Physicians are consulting Gemini before prescribing. Regulators are building their own AI review

How ChatGPT, Gemini, and a dozen other AI chatbots became the most unmonitored channel in pharmaceutical brand strategy — and

The medical information landscape has shifted from static search results to dynamic, generative responses. While pharmaceutical companies have spent decades